Cell-mediated immune responses in tuberculosis.

Tuberculosis is primarily a disease of the lung, and dissemination of the disease depends on productive infection of this critical organ. Upon aerosol infection with Mycobacterium tuberculosis (Mtb), the acquired cellular immune response is slow to be induced and to be expressed within the lung. This slowness allows infection to become well established; thus, the acquired response is expressed in an inflammatory site that has been initiated and modulated by the bacterium. Mtb has a variety of surface molecules that interact with the innate response, and this interaction along with the autoregulation of the immune response by several mechanisms results in less-than-optimal control of bacterial growth. To improve current vaccine strategies, we must understand the factors that mediate induction, expression, and regulation of the immune response in the lung. We must also determine how to induce both known and novel immunoprotective responses without inducing immunopathologic consequences.

[1]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[2]  S. Hickman,et al.  Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to Mycobacterium tuberculosis Is Due to Use of Distinct TLRs1 , 2007, The Journal of Immunology.

[3]  I. Orme,et al.  Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  B. Lichty,et al.  Mucosal Luminal Manipulation of T Cell Geography Switches on Protective Efficacy by Otherwise Ineffective Parenteral Genetic Immunization1 , 2007, The Journal of Immunology.

[5]  L. Kobzik,et al.  Progression of Pulmonary Tuberculosis and Efficiency of Bacillus Calmette-Guérin Vaccination Are Genetically Controlled via a Common sst1-Mediated Mechanism of Innate Immunity1 , 2007, The Journal of Immunology.

[6]  L. Ramakrishnan,et al.  Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. , 2002, Immunity.

[7]  A. J. Crowle,et al.  Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages , 1987, Infection and immunity.

[8]  S. Nakae,et al.  IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guérin Infection1 , 2007, The Journal of Immunology.

[9]  J. Flynn,et al.  IL-17 Production Is Dominated by γδ T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[10]  R. North,et al.  Immunity to tuberculosis. , 2003, Annual review of immunology.

[11]  T. Mak,et al.  The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis 1 , 2005, The Journal of Immunology.

[12]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[13]  R. Wilkinson,et al.  IFN--and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37 , 2007 .

[14]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[15]  S. Khader,et al.  Interleukin-12 and tuberculosis: an old story revisited. , 2007, Current opinion in immunology.

[16]  G. Besra,et al.  Mycolic Acid Modification by the mmaA4 Gene of M. tuberculosis Modulates IL-12 Production , 2008, PLoS pathogens.

[17]  C. Bonorino,et al.  Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[19]  Scott N. Mueller,et al.  Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection , 2007, Proceedings of the National Academy of Sciences.

[20]  N. Reiling,et al.  Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.

[21]  I. Orme,et al.  Effective Preexposure Tuberculosis Vaccines Fail To Protect When They Are Given in an Immunotherapeutic Mode , 2000, Infection and Immunity.

[22]  S. Furney,et al.  T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. , 1992, Journal of immunology.

[23]  B. Ryffel,et al.  IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection , 2007, The Journal of Immunology.

[24]  Ronald N Germain,et al.  Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. , 2008, Immunity.

[25]  R. Appelberg,et al.  The thymus as a target for mycobacterial infections. , 2007, Microbes and infection.

[26]  A. Sher,et al.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis , 2005, The Journal of experimental medicine.

[27]  S. Hickman,et al.  Cutting Edge: A New Approach to Modeling Early Lung Immunity in Murine Tuberculosis1 , 2004, The Journal of Immunology.

[28]  H. McShane,et al.  Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans , 2004, Nature Medicine.

[29]  A. Sharafkhaneh,et al.  Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. , 2007, Immunity.

[30]  R. Koenig In South Africa, XDR TB and HIV Prove a Deadly Combination , 2008, Science.

[31]  M. Reed,et al.  Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. , 2005, The Journal of infectious diseases.

[32]  A. Apt,et al.  Comparative Analysis of T Lymphocytes Recovered from the Lungs of Mice Genetically Susceptible, Resistant, and Hyperresistant to Mycobacterium tuberculosis-Triggered Disease1 , 2000, The Journal of Immunology.

[33]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[34]  G. Kaplan,et al.  The Phenolic Glycolipid of Mycobacterium tuberculosis Differentially Modulates the Early Host Cytokine Response but Does Not in Itself Confer Hypervirulence , 2008, Infection and Immunity.

[35]  S. Khader,et al.  IL-23 and IL-17 in tuberculosis. , 2008, Cytokine.

[36]  M. Reed,et al.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.

[37]  W. Jacobs,et al.  Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Dockrell,et al.  Persistence of the immune response induced by BCG vaccination , 2008, BMC infectious diseases.

[39]  Eun-Kyeong Jo,et al.  Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs , 2008, Current opinion in infectious diseases.

[40]  J. Flynn,et al.  CD8+ T Cells Participate in the Memory Immune Response to Mycobacterium tuberculosis , 2001, Infection and Immunity.

[41]  J. Casanova,et al.  Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. , 1998, Immunology today.

[42]  J. Chan,et al.  B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis1 , 2007, The Journal of Immunology.

[43]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[44]  C. Harding,et al.  Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein , 2004, Infection and Immunity.

[45]  I. Orme,et al.  Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis , 2003, Infection and Immunity.

[46]  L. Ramakrishnan,et al.  Superinfecting mycobacteria home to established tuberculous granulomas , 2004, Nature Immunology.

[47]  James A. Raleigh,et al.  Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates , 2008, Infection and Immunity.

[48]  W. Jacobs,et al.  Potent Inhibition of Macrophage Responses to IFN-γ by Live Virulent Mycobacterium tuberculosis Is Independent of Mature Mycobacterial Lipoproteins but Dependent on TLR21 , 2006, Journal of Immunology.

[49]  M. Veldhoen,et al.  Differentiation of human TH-17 cells does require TGF-β! , 2008, Nature Immunology.

[50]  G. Besra,et al.  ActivationRegulation of CD1d Expression and NKT Cell Interplay of Cytokines and Microbial Signals in , 2005 .

[51]  M. Glickman,et al.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.

[52]  Robert J Wilkinson,et al.  IFN-γ- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-371 , 2007, The Journal of Immunology.

[53]  S. Swain,et al.  Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection , 2006, The Journal of experimental medicine.

[54]  A. Rudensky,et al.  Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis , 2007, The Journal of experimental medicine.

[55]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[56]  S. Ehlers,et al.  Granulocytes Accelerated and Enhanced Recruitment of Tuberculosis in Mice Causally Involves Genetically Determined Susceptibility To , 2022 .

[57]  M. Daly,et al.  Ipr1 gene mediates innate immunity to tuberculosis , 2005, Nature.

[58]  Yue Wang,et al.  Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. , 2005, Journal of immunology.

[59]  S. Kaufmann,et al.  Cutting Edge: Regulatory T Cells Prevent Efficient Clearance of Mycobacterium tuberculosis , 2007, The Journal of Immunology.

[60]  L. Liotta,et al.  Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma. , 1992, Journal of immunological methods.

[61]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[62]  P. Holt,et al.  Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. , 1994, Journal of immunology.

[63]  C. Demangel,et al.  Autocrine IL‐10 impairs dendritic cell (DC)‐derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL‐12 production , 2002, European journal of immunology.

[64]  S. Salzberg,et al.  Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains , 2002, Journal of bacteriology.

[65]  I. Orme,et al.  The Cellular Immune Response to Mycobacterium tuberculosis Infection in the Guinea Pig1 , 2007, The Journal of Immunology.

[66]  R. Kradin,et al.  The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen , 1995, The Journal of experimental medicine.

[67]  A. Sher,et al.  NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis , 2006, The Journal of Immunology.

[68]  C S Berkey,et al.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. , 1994, JAMA.

[69]  C. Harding,et al.  Prolonged Toll-Like Receptor Signaling by Mycobacterium tuberculosis and Its 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Induced Regulation of Selected Genes in Macrophages , 2004, Infection and Immunity.

[70]  S. Akira,et al.  Mycobacterial Infection in TLR2 and TLR6 Knockout Mice , 2003, Microbiology and immunology.

[71]  I. Orme,et al.  Temporal and Spatial Arrangement of Lymphocytes within Lung Granulomas Induced by Aerosol Infection withMycobacterium tuberculosis , 2001, Infection and Immunity.

[72]  I. Orme,et al.  Characterization of Murine Lung Dendritic Cells Infected with Mycobacterium tuberculosis , 2001, Infection and Immunity.

[73]  R. Appelberg,et al.  Neutrophil-macrophage cooperation in the host defence against mycobacterial infections. , 1989, Microbial pathogenesis.

[74]  R. North,et al.  The Relative Importance of T Cell Subsets in Immunity and Immunopathology of Airborne Mycobacterium tuberculosis Infection in Mice , 2001, The Journal of experimental medicine.

[75]  Bing Chen,et al.  Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. , 2007, The Journal of clinical investigation.

[76]  R. Wilkinson,et al.  Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response1 , 2008, The Journal of Immunology.

[77]  J. Ernst,et al.  Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo1 , 2007, The Journal of Immunology.

[78]  A. Adegnika,et al.  Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa. , 2005, Microbes and infection.

[79]  A. Pacheco,et al.  IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study , 2008, Human Genetics.

[80]  Sugata Roy,et al.  NK Cells Lyse T Regulatory Cells That Expand in Response to an Intracellular Pathogen1 , 2008, The Journal of Immunology.

[81]  Carmen M. Collazo-Custodio,et al.  Mice Lacking Myeloid Differentiation Factor 88 Display Profound Defects in Host Resistance and Immune Responses to Mycobacterium avium Infection Not Exhibited by Toll-Like Receptor 2 (TLR2)- and TLR4-Deficient Animals , 2003, The Journal of Immunology.

[82]  W. Jacobs,et al.  Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[83]  D. Havlir,et al.  Tuberculosis in patients with human immunodeficiency virus infection. , 1999, The New England journal of medicine.

[84]  J. Keane,et al.  T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. , 2007, Immunity.

[85]  Yu-Jin Jung,et al.  Increased interleukin‐10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice , 2003, Immunology.

[86]  Yu-Jin Jung,et al.  Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice , 2005, The Journal of experimental medicine.

[87]  T. Ganz,et al.  Macrophages Acquire Neutrophil Granules for Antimicrobial Activity against Intracellular Pathogens1 , 2006, The Journal of Immunology.

[88]  A. Sher,et al.  Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. , 2005, The Journal of clinical investigation.

[89]  I. Orme,et al.  Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[90]  Alan D. Roberts,et al.  ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes , 2008, Proceedings of the National Academy of Sciences.

[91]  Rich Ar,et al.  The pathogenesis of tuberculosis , 1951 .

[92]  Gregory A. Taylor,et al.  Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47 , 2003, Science.

[93]  M. Yadav,et al.  The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. , 2006, Blood.

[94]  R. North Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. , 1995, The Journal of infectious diseases.

[95]  M. Glickman,et al.  Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule , 2005, The Journal of experimental medicine.

[96]  G. Kaplan,et al.  Bacillus Calmette Guerin Vaccination of Human Newborns Induces a Specific, Functional CD8+ T Cell Response1 , 2006, The Journal of Immunology.

[97]  M. J. Lefford Transfer of Adoptive Immunity to Tuberculosis in Mice , 1975, Infection and immunity.

[98]  S. Akira,et al.  Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, ‐4 and ‐9 , 2008, European journal of immunology.

[99]  P. Gros,et al.  Fibrotic Response as a Distinguishing Feature of Resistance and Susceptibility to Pulmonary Infection with Mycobacterium tuberculosis in Mice , 2007, Infection and Immunity.

[100]  Stefan Niemann,et al.  Definition of the Beijing/W Lineage of Mycobacterium tuberculosis on the Basis of Genetic Markers , 2004, Journal of Clinical Microbiology.

[101]  Bjoern Peters,et al.  An analysis of the epitope knowledge related to Mycobacteria , 2007, Immunome research.

[102]  I. Orme,et al.  Foamy Macrophages within Lung Granulomas of Mice Infected with Mycobacterium tuberculosis Express Molecules Characteristic of Dendritic Cells and Antiapoptotic Markers of the TNF Receptor-Associated Factor Family1 , 2005, The Journal of Immunology.

[103]  J. Gauldie,et al.  Mucosally Delivered Dendritic Cells Activate T Cells Independently of IL-12 and Endogenous APCs1 , 2008, The Journal of Immunology.

[104]  I. Orme The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. , 1987, Journal of immunology.

[105]  C. Dascher,et al.  Dissemination of Mycobacterium tuberculosis Is Influenced by Host Factors and Precedes the Initiation of T-Cell Immunity , 2002, Infection and Immunity.

[106]  G. Rook,et al.  Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.

[107]  Matthew S. Cook,et al.  Immunodominant Tuberculosis CD8 Antigens Preferentially Restricted by HLA-B , 2007, PLoS pathogens.

[108]  I. Orme,et al.  The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.

[109]  Scott N. Mueller,et al.  Regulation of Homeostatic Chemokine Expression and Cell Trafficking During Immune Responses , 2007, Science.

[110]  N. Rawal,et al.  Vimentin Expressed on Mycobacterium tuberculosis-Infected Human Monocytes Is Involved in Binding to the NKp46 Receptor1 , 2006, The Journal of Immunology.

[111]  J. Flynn,et al.  The Chemokine Receptor CXCR3 Attenuates the Control of Chronic Mycobacterium tuberculosis Infection in BALB/c Mice1 , 2007, The Journal of Immunology.

[112]  V. Deretic,et al.  Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages , 2004, Cell.

[113]  P. Klenerman,et al.  Dynamic Relationship between IFN-γ and IL-2 Profile of Mycobacterium tuberculosis-Specific T Cells and Antigen Load1 , 2007, The Journal of Immunology.

[114]  A. Sher,et al.  Dectin-1 Interaction with Mycobacterium tuberculosis Leads to Enhanced IL-12p40 Production by Splenic Dendritic Cells1 , 2007, The Journal of Immunology.

[115]  L. Fiette,et al.  Dendritic Cells Are Host Cells for Mycobacteria In Vivo That Trigger Innate and Acquired Immunity1 , 2002, The Journal of Immunology.

[116]  D. Flaherty,et al.  Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.

[117]  A. Azad,et al.  Role of C-type lectins in mycobacterial infections. , 2008, Current drug targets.

[118]  R. Modlin,et al.  Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on the Induction of Cathelicidin1 , 2007, The Journal of Immunology.

[119]  O. Mandelboim,et al.  The NKp46 Receptor Contributes to NK Cell Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium1 , 2002, The Journal of Immunology.

[120]  J. Kirman,et al.  Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. , 2007, Tuberculosis.

[121]  J. Gauldie,et al.  Critical Negative Regulation of Type 1 T Cell Immunity and Immunopathology by Signaling Adaptor DAP12 during Intracellular Infection1 , 2007, The Journal of Immunology.

[122]  Y. Kooyk,et al.  C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB , 2007 .

[123]  Mahavir Singh,et al.  Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen. , 2008, Human immunology.

[124]  M. Newport,et al.  Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. , 2002, The Journal of infectious diseases.

[125]  A. Casadevall,et al.  Fcγ Receptors Regulate Immune Activation and Susceptibility during Mycobacterium tuberculosis Infection1 , 2008, The Journal of Immunology.

[126]  R. North Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. , 1973, Cellular immunology.

[127]  M. Pavelka,et al.  Codominance of TLR2-Dependent and TLR2-Independent Modulation of MHC Class II in Mycobacterium tuberculosis Infection In Vivo1 , 2007, The Journal of Immunology.

[128]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[129]  F. Mosteller,et al.  Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature , 1994 .

[130]  M. Barral-Netto,et al.  Lung granulomas from Mycobacterium tuberculosis/HIV-1 co-infected patients display decreased in situ TNF production. , 2008, Pathology, research and practice.

[131]  S. Fortune,et al.  Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.

[132]  K. Elkins,et al.  Infection of B Cell-Deficient Mice with CDC 1551, a Clinical Isolate of Mycobacterium tuberculosis: Delay in Dissemination and Development of Lung Pathology1 , 2000, The Journal of Immunology.

[133]  Annemarie H Meijer,et al.  Identification and real-time imaging of a myc-expressing neutrophil population involved in inflammation and mycobacterial granuloma formation in zebrafish. , 2008, Developmental and comparative immunology.

[134]  S. Kaufmann,et al.  Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs. , 2007, The Journal of infectious diseases.

[135]  G. Trinchieri,et al.  Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells , 2008, The Journal of experimental medicine.

[136]  C. Harding,et al.  Inhibition of IFN-γ-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein from Mycobacterium tuberculosis: A Potential Mechanism for Immune Evasion1 , 2003, The Journal of Immunology.

[137]  R. Steinman,et al.  Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo , 1993, The Journal of experimental medicine.

[138]  B. Ryffel,et al.  Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. , 2004, The Journal of clinical investigation.

[139]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[140]  V. Deretic,et al.  Human IRGM Induces Autophagy to Eliminate Intracellular Mycobacteria , 2006, Science.

[141]  J. Flynn,et al.  Immunology of tuberculosis. , 2003, Annual review of immunology.

[142]  C. Harding,et al.  The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2 , 2003, Infection and Immunity.

[143]  H. McShane,et al.  Recombinant Modified Vaccinia Virus Ankara Administration and Boosting with a Bacille Calmette-Guérin Vaccine Using Mucosal of Mycobacterium tuberculosis Efficacy Against Enhanced Immunogenicity and Protective , 2003 .

[144]  Christopher Dye,et al.  Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .

[145]  F. Dieli,et al.  Phenotypical and Functional Analysis of Memory and Effector Human CD8 T Cells Specific for Mycobacterial Antigens1 , 2006, The Journal of Immunology.

[146]  Daniel J Klionsky,et al.  Development by self-digestion: molecular mechanisms and biological functions of autophagy. , 2004, Developmental cell.

[147]  J. Ernst,et al.  Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs , 2008, The Journal of experimental medicine.

[148]  I. Orme,et al.  In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.

[149]  F. Gao,et al.  Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. , 2006, The Journal of clinical investigation.

[150]  I. Orme,et al.  Factors Associated with Severe Granulomatous Pneumonia in Mycobacterium tuberculosis-Infected Mice Vaccinated Therapeutically with hsp65 DNA , 2005, Infection and Immunity.

[151]  S. Khader,et al.  IL-23 Compensates for the Absence of IL-12p70 and Is Essential for the IL-17 Response during Tuberculosis but Is Dispensable for Protection and Antigen-Specific IFN-γ Responses if IL-12p70 Is Available1 , 2005, The Journal of Immunology.

[152]  Michael D. Liang,et al.  TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG , 2003, Journal of leukocyte biology.

[153]  S. Behar,et al.  Gamma Interferon-Producing CD4+ T Lymphocytes in the Lung Correlate with Resistance to Infection withMycobacterium tuberculosis , 2001, Infection and Immunity.

[154]  S. Behar,et al.  Tuberculosis Triggers a Tissue-Dependent Program of Differentiation and Acquisition of Effector Functions by Circulating Monocytes1 , 2008, The Journal of Immunology.

[155]  H. Vordermeier,et al.  Increase of tuberculous infection in the organs of B cell‐deficient mice , 1996, Clinical and experimental immunology.

[156]  P. Holt,et al.  Anatomical Location Determines the Distribution and Function of Dendritic Cells and Other APCs in the Respiratory Tract1 , 2005, The Journal of Immunology.

[157]  R. Al-Attiyah,et al.  Characterization of Human Cellular Immune Responses to Novel Mycobacterium tuberculosis Antigens Encoded by Genomic Regions Absent in Mycobacterium bovis BCG , 2008, Infection and Immunity.

[158]  I. Orme,et al.  CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. , 2002, Cellular immunology.

[159]  S. Kaufmann,et al.  Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. , 2005, The Journal of clinical investigation.

[160]  Ariza,et al.  The Intravenous Model of Murine Tuberculosis is Less Pathogenic Than the Aerogenic Model Owing to a More Rapid Induction of Systemic Immunity , 1999, Scandinavian journal of immunology.

[161]  S. Ehlers,et al.  Oxygen status of lung granulomas in Mycobacterium tuberculosis‐infected mice , 2006, The Journal of pathology.

[162]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[163]  S. Ehlers,et al.  IFN-γ and NO in mycobacterial disease: new jobs for old hands , 2002 .

[164]  R. Wilkinson,et al.  Neutrophil-mediated innate immune resistance to mycobacteria. , 2007, The Journal of clinical investigation.

[165]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[166]  G. Kaplan,et al.  Bacillus Calmette-Guérin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles1 , 2008, The Journal of Immunology.

[167]  D. Golenbock,et al.  Toll-Like Receptor 2-Dependent Inhibition of Macrophage Class II MHC Expression and Antigen Processing by 19-kDa Lipoprotein of Mycobacterium tuberculosis1 , 2001, The Journal of Immunology.

[168]  A. Sher,et al.  MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression , 2004, Infection and Immunity.

[169]  A. Sher,et al.  Parasite-induced Lipoxin A4 Is an Endogenous Regulator of IL-12 Production and Immunopathology in Toxoplasma gondii Infection , 2002, The Journal of experimental medicine.

[170]  M. Perkins,et al.  Confronting the scientific obstacles to global control of tuberculosis. , 2008, The Journal of clinical investigation.

[171]  F. Collins,et al.  Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. , 2001, Tuberculosis.

[172]  D. Snider,et al.  Tuberculosis in patients with human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[173]  I. Orme,et al.  Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients , 1983, The Journal of experimental medicine.

[174]  A. Porgador,et al.  Role of NK Cell-Activating Receptors and Their Ligands in the Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium1 , 2005, The Journal of Immunology.

[175]  S. Khader,et al.  IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice1 , 2004, The Journal of Immunology.

[176]  R. Koup,et al.  Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations , 2007, European journal of immunology.

[177]  R. Appelberg,et al.  Neutrophils and intracellular pathogens: beyond phagocytosis and killing. , 2007, Trends in microbiology.

[178]  J. Mudgett,et al.  Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.